NCT04648579

Brief Summary

The documentation of vital signs is traditionally performed manually when the patient is not admitted in intensive care units, which can lead to documentary errors, long time for data acquisition and, consequently, impairment in the early identification of possible clinical deterioration. In-bed technology solutions are available to automate the collection of vital data and transfer information to a medical record or central electronic monitoring and its role in the health value chain needs further investigation. The investigators propose to evaluate the impact of the Connex Spot Monitor solution Welch Allyn (CSM / Hillrom) in conjunction with the Hillrom Connecta solution in a real world situation, conducting a cluster randomized trilal in wards of a tertiary hospital. In addition, this study aims to estimate the clinical effectiveness of a technological solution that performs an analysis of vital signs and automatically activates the rapid response team (RRT) when the pre-defined criteria are met, comparing it with the traditional manual method. The primary outcome is the number of times that the RRT fires in a timely manner.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
231

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Apr 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 23, 2020

Completed
8 days until next milestone

First Posted

Study publicly available on registry

December 1, 2020

Completed
5 months until next milestone

Study Start

First participant enrolled

April 22, 2021

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2021

Completed
1.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2022

Completed
Last Updated

March 1, 2023

Status Verified

February 1, 2022

Enrollment Period

5 months

First QC Date

November 23, 2020

Last Update Submit

February 28, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • RRT

    Number of rapid response team triggers activated in a timely manner.

    24 hours

Study Arms (2)

Hillrom

EXPERIMENTAL

The intervention involves an automated vital signs document system consisting of a mobile medical device for measuring vital signs (CSM / Hillrom) that collects and analyzes data acquired at the bedside to be sent to a remote data processing point (Digital Control Station), using Hillrom Connecta software.

Device: Hillrom

Control

ACTIVE COMPARATOR

Hospital usual care.

Other: Control

Interventions

HillromDEVICE

Hillrom Connecta solution will record vital signs in an automated way, without the need for human intervention, and activate TRR activation when at least one criteria is met. The frequency of monitoring vital signs will be defined based on the MEWS score.

Hillrom
ControlOTHER

Hospital usual care regarding vital signs collection and TRR activation.

Control

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \- All patients with activated RRT during the study recruitment period.

You may not qualify if:

  • \- Individuals who need blood pressure measurement in lower members.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital do Coracao

São Paulo, São Paulo, Brazil

Location

Related Publications (1)

  • Ribeiro JC, Sgorbissa C, Silva KA, Braz MLD, Horak ACP, Nicola ML, Gurgel RM, Tokunaga SM, Negrelli KL, Murizine GS, Medrado Junior F, Coli RCP, Cavalcanti AB, Marcadenti A. Automated documentation of vital parameters in wards using portable stations - Effect on proper triggering of the rapid response team: a study protocol of a cluster randomized clinical trial. Rev Bras Ter Intensiva. 2022 Nov 4;34(3):319-326. doi: 10.5935/0103-507X.20220101-pt. eCollection 2022.

Study Officials

  • José César Ribeiro, RN

    Hospital do Coracao

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 23, 2020

First Posted

December 1, 2020

Study Start

April 22, 2021

Primary Completion

September 30, 2021

Study Completion

December 30, 2022

Last Updated

March 1, 2023

Record last verified: 2022-02

Data Sharing

IPD Sharing
Will share

Anonymized data will be available upon reasonable request including a short study protocol. Both sponsor and funders will evaluate all requests. Brazilian regulatory agencies approval will be also required.

Shared Documents
STUDY PROTOCOL
Time Frame
After main paper publication.

Locations